The foundation: 35 years of pigmentation expertise
The journey to Melasyl™ began decades ago, as L'Oréal Research began to build out the foundational knowledge that would make this innovation possible. Here’s how it happened.
1996: Developing the models
In 1996, L’Oréal Research began engineering reconstructed skin models designed to mimic how human skin produces and distributes melanin*.
Melanin is the natural pigment that gives skin its colour. When cells produce too much in one area, that excess pigment causes dark spots and uneven tone.
To study this process more closely, our scientists needed a model that could reflect real skin biology across different phototypes – the scale used to classify how skin responds to sun exposure.
These reconstructed models became essential tools in Melasyl™ research. They allowed our scientists to observe how pigment forms, moves through the skin, and gradually accumulates into visible discolouration.
Understanding the issue
Through this research, our scientists developed a deeper understanding of the biological processes that drive hyperpigmentation.
We identified:
- How dark spots develop differently across skin tones.
- What can cause discolouration to become more persistent.
- Why existing brightening ingredients have inconsistent efficacy.
This research led to a critical insight: many traditional brightening formulas target tyrosinase, an enzyme that plays a key role in melanin production. While inhibiting tyrosinase can help reduce the formation of excess pigment, it only affects one stage of a complex, multi-stage pigmentation pathway.
To create a more advanced solution, L’Oréal Research theorised that we needed to intervene earlier in the process – before excess melanin could accumulate and become visible as dark spots.
2006–2008: The search begins
Jump forward to the turn of the millennium. With decades of pigmentation knowledge under its belt, L'Oréal Research launched a comprehensive program to identify a new class of brightening actives.
The goal was ambitious: find a molecule that targeted pigmentation in a completely new way, reduced dark spots more effectively across different skin tones, and met our rigorous safety and environmental standards.
High-throughput screening of 100,000 molecules
The discovery of Melasyl™ emerged from a comprehensive research program involving the high-throughput screening of more than 100,000 molecules*.
This was not a process of random testing. Our scientists used a systematic approach to evaluate each molecule against multiple criteria:
Screening criterion | What we evaluated | Why it mattered |
Physicochemical properties | How each molecule behaved chemically, including its stability and compatibility in a skincare formula | Ensured the molecule could be formulated effectively and remain stable over time |
Efficiency | How effectively the molecule reduced the biological process that led to dark spots | Identified candidates with strong potential to visibly reduce hyperpigmentation |
Environmental profile | Water footprint and ecological impact | Ensured the molecule met our high environmental standards |
Performance across skin tones | How consistently the molecule worked across diverse skin tones | Increased the likelihood of effective results for a broad population |
2008: Identifying the first candidate
After screening more than 100,000 molecules, L’Oréal Research identified the first promising molecule of this chemical type in 2008*.
Belonging to a chemical family known as thiopyridinones – compounds that share a similar structure – early testing showed that this family had strong potential to help reduce dark spots. But, as tests progressed, not every thiopyridinone performed equally well.
Our scientists continued testing this promising family of molecules to identify the candidate that delivered the strongest results.
The molecule that emerged from this research would later be named Melasyl™.
2008–2010: From discovery to understanding
Identifying a promising molecule was only the beginning. L’Oréal Research now needed to answer three critical questions:
- How does this molecule act on the pigmentation pathway?
- Why is it effective at reducing visible dark spots?
- Does it deliver better results than existing brightening ingredients?
To answer these questions, our scientists started by investigating how Melasyl™ (2-MNG at the time) acts within the pigmentation pathway.
Unveiling the mechanism: Melanin precursor interception
Our research showed that Melasyl™ works differently from traditional brightening ingredients. Instead of inhibiting tyrosinase, Melasyl™ binds to melanin precursors – colourless molecules, such as dopaquinone, that would normally be converted into pigment*.
When Melasyl™ reacts with dopaquinone, it forms a stable compound known as 6-MNG-DOPA. Because this compound cannot be converted into melanin, less excess pigment is available to build up into visible dark spots*.
Step in pigmentation | What normally happens | What Melasyl™ does |
Melanin precursors form | Colourless molecules such as dopaquinone are produced | Melasyl™ (2-MNG) binds to these molecules |
Pigment develops | These molecules are converted into melanin | Stable compounds such as 6-MNG-DOPA are formed instead |
Dark spots appear | Excess melanin accumulates in the skin | Less excess pigment is available to build up |
Our scientists confirmed this mechanism in melanocyte cell cultures*. When they increased L-tyrosine – a natural building block of melanin – they observed greater formation of 6-MNG-DOPA.
What does this all mean? That, after years of research, our scientists finally had the proof they were looking for: that Melasyl™ reduces dark spots by intercepting excess melanin precursors before they can become visible pigment*.
2010: Patenting the family
To protect this discovery, we patented the chemical family that included Melasyl™ in 2010*. This milestone recognised the advanced nature of this chemical class and secured our intellectual property rights to continue developing the most promising molecules.
2010–2015: Optimisation and validation
With the mechanism understood and the chemical family patented, L’Oréal Research moved into the next stage: finding the strongest candidate and proving it could perform safely across different skin tones.
Selecting the optimal candidate
The first step was to identify which thiopyridinone molecule showed the strongest potential.
Among the candidates, Melasyl™ stood out because it offered the strongest balance of efficacy, tolerance, and environmental performance*.
To progress, the molecule needed to:
- Perform consistently across all skin tones.
- Show a strong safety profile, including on sensitive skin.
- Deliver stronger brightening ability than existing actives.
- Demonstrate a favourable water footprint and low environmental impact*.
Melasyl™ met these criteria, making it the optimal candidate to move into further testing and clinical development.
Extensive testing on cells and reconstructed skin
Before Melasyl™ could be formulated into skincare products, L’Oréal Research tested it on cells and reconstructed skin models to confirm its efficacy, safety, and environmental profile.
This stage drew on the reconstructed skin models we had been developing since 1996. Because these models closely replicate human skin, they enabled our scientists to study how Melasyl™ behaved in conditions that reflected real skin biology.
The studies showed that Melasyl™ binds to several early pigment-building molecules: including dopaquinone, DHICA-quinone, and DHI-quinone*. By capturing these molecules before they become part of melanin, Melasyl™ helps reduce excess pigment formation earlier in the pathway – creating a new approach to managing skin pigmentation.
2015: The specific patent
By 2015, the first specific patent for Melasyl™ had been issued*. It was no longer just a promising molecule in the lab – Melasyl™ had been studied, tested, and shown to have proven potential in helping address hyperpigmentation.
2015–2020: Clinical validation across diverse populations
With Melasyl™ identified, characterised, and proven safe in laboratory settings, L’Oréal Research moved into clinical validation – testing Melasyl™ on real people across Fitzpatrick phototypes I to VI.
Because dark spots can form and fade differently across skin tones, this stage was designed to confirm that Melasyl™ could deliver visible results across diverse populations.
Rigorous clinical study design
We tested Melasyl™ in several ways before confirming its efficacy. This included in vitro studies in the lab, ex vivo studies on skin samples, and in vivo studies on real people*.
The most important stage was clinical testing on human volunteers across diverse skin tones. These studies used a double-blind, randomised design – one of clinical research’s strongest methods – to test formulas containing 0.5% and 1% 2-MNG (Melasyl™) *.
In these studies, some participants used a formula containing Melasyl™, while others used a vehicle control – the same formula, just without Melasyl™. Because neither participants nor evaluators knew who received which formula, the study design helped reduce bias and strengthen the reliability of the results*.
Demonstrating efficacy across all skin tones
One study showed that Melasyl™ helps prevent and reduce UV-induced pigmentation across Fitzpatrick phototypes I to VI*. Meaning Melasyl™ was clinically shown to work equally well on very fair skin (phototype I) as on very dark skin (phototype VI).
A separate three-month clinical study focused on Asian and Chinese volunteers with Fitzpatrick phototypes III, IV, and V*. In this study, a formula containing 0.5% Melasyl™ visibly reduced UV-induced pigmentation by helping delay melanin formation.
Together, these studies helped validate that Melasyl™ can deliver visible results across diverse complexions.
Proving superior performance
But could Melasyl™ out-perform other recognised brightening ingredients?
A meta-analysis found that 0.5% Melasyl™ showed statistically superior anti-pigmentation performance when compared to a range of more than 10 other recognised skincare ingredients for dark spots on the market, including Vitamin C, kojic acid, niacinamide, and arbutin*.
Demonstrating safety without adverse effects
For L’Oréal Research, efficacy was only one part of the equation. The goal was to develop a brightening ingredient that was well tolerated across different skin types.
Our clinical studies showed that Melasyl™ helped prevent UV-induced immediate skin darkening and inhibit delayed tanning, without adverse effects*.
In other words, Melasyl™ delivered dramatic brightening results while maintaining excellent tolerance across all skin types.
Safety and environmental commitment
Throughout Melasyl™'s research and development, we maintained an unwavering commitment to both human safety and our environmental responsibility.
Testing – without animal testing
Instead of testing on animals, our researchers used advanced alternative methods, including Episkin reconstructed skin – a validated skin model pioneered by L’Oréal Research in the 1970s*.
Designed to closely mimic human skin, Episkin helped researchers assess Melasyl™ in a way that was more relevant to real skin, while supporting our commitment to cruelty-free research and beauty without animal testing*. L’Oréal has been committed to beauty without animal testing for over 30 years and pioneered the development of alternative methods.
Environmental profile
From an environmental perspective, Melasyl™ was selected not just for its efficacy but also for its minimised water footprint and low environmental impact*.
The development process demonstrated a thoughtful compromise between efficacy, safety, bioavailability, and environmental considerations.
2020–2024: Formulation and final validation
With Melasyl™’s efficacy and safety proven, it was time to formulate it into consumer-accessible skincare that would get rid of dark spots and hyperpigmentation.
Developing synergistic formulations
When testing Melasyl™ with other skincare ingredients, L’Oréal Research discovered that niacinamide worked particularly well alongside Melasyl™, increasing efficacy in visibly reducing dark spots and improving overall skin tone*.
Niacinamide helps limit excess melanin production and reduces the transfer of pigment to the surface of the skin, while Melasyl™ helps intercept melanin precursors before they are converted into visible pigment.
By combining these complementary mechanisms, we could target multiple stages of the pigmentation process to help prevent and visibly reduce hyperpigmentation*.
The revolutionary texture
Melasyl™ research didn’t stop at the ingredients. We also wanted our serum texture to feel immediately comfortable on the skin*.
That led us to develop our Creamy Serum – a highly moisturising and sensorial texture that absorbs quickly like a serum, while delivering the feel of a cream. Its lightweight yet nourishing texture was designed for twice-daily application, making it easy to incorporate into both AM and PM skincare routines for dark spots.
Final clinical validation: Revitalift Laser Melasyl™ Anti-Ageing Creamy-Serum
After 18 years of research, we finally had it – Revitalift MelasyI™ Anti-Ageing Creamy Serum by L’Oréal Paris.
To evaluate the serum’s performance, we conducted a clinical study involving 70 women across skin phototypes I to VI:
Category | Result |
Participants | 70 women across skin phototypes I to VI |
Early visible results | Improvements in dark spots, wrinkles, and dullness after 7 days |
Clinical efficiency | Up to 86% reduction in dark spots after 8 weeks (clinically proven and notary certified) *. |
Comfort | 97% felt their skin was comfortable all day long*. |
Social confidence | 94% received compliments on their skin*. |
2024: Global launch and recognition
On March 11, 2024, we officially launched Melasyl™ to the world, marking the culmination of decades of research and the beginning of a new era in the treatment of different types of spots: including dark spots, post-blemish marks, and melasma/age spots.
23 global patents
Globally, a total of 23 patents have been filed to protect this innovation.*
The science behind Melasyl™ was so novel that we secured intellectual property for every major stage of its development – from discovering the molecule and formulating it into a skincare product to clinically validating its efficacy across a variety of skin tones*.
121 scientific studies
With 121 scientific studies underpinning its development, Melasyl™ represents one of the most thoroughly researched cosmetic ingredients ever created*.
Behind every claim was a study, every mechanism was closely examined, and every result was validated across diverse populations*.
Recognition by TIME Magazine
The impact of Melasyl™ extended far beyond our laboratories and scientific journals. In 2025, TIME Magazine named Melasyl™ one of the Best Inventions of the Year.
For us, this recognition was a powerful reminder that our research had the potential to help millions of people around the world visibly reduce uneven skin tone and dark spots.
The human impact: Why this journey mattered
Melasyl™ is now formulated into our best serums for hyperpigmentation and brightening. Below, we explain why our goal was not only to discover a breakthrough molecule, but to turn advanced science into accessible skincare.
Addressing a global concern
Hyperpigmentation is one of the most common skin concerns worldwide.
In Australia alone, melasma – a common form of hyperpigmentation – is estimated to affect around five million people*. For Elisabeth Bouhadana, L’Oréal Paris Scientific Director, this reflects a wider truth about skin ageing:
“Our understanding of skin ageing is built on clinical studies across seven international R&I hubs and the analysis of 17,000 calibrated ageing signs. This research revealed a universal need: regardless of skin type or tone, women experience wrinkles and dark spots as key signs of ageing.”
The need for accessibility
For many people, dark spots can feel difficult to treat without professional cosmetic procedures, such as laser treatments or in-clinic resurfacing. Melasyl™ research helped create skincare designed to visibly reduce dark spots through a daily at-home routine.
You can find Melasyl™ in our Bright Reveal 10% [Niacinamide + Melasyl™ + Amino-Sulfonic Acid] Dark Spot Serum, formulated to target the look of sunspots, age spots, and post-blemish hyperpigmentation. In eight weeks, dark spots can be reduced by 77%, with a 25% increase in skin radiance1.
For those also targeting visible signs of ageing, Revitalift MelasyI™ Anti-Ageing Creamy Serum helps reduce the appearance of dark spots, wrinkles, and dullness, while helping reverse up to 15 years of visible dark spots2.
1Cosmeto-clinical study, 62 subjects, after 8 weeks + 3 weeks remanence. 2Self-assessments on the look of dark spots and radiance, 239 women The future of brightening science – three principles
Our 18-year journey to Melasyl™ shows where modern brightening science is heading.
Read on for the three principles that shaped our research and continue to help us chart our course to future skincare innovation.
1. Time and patience
Strong scientific advances need time, research, and proof. Melasyl™ took 18 years to develop because each stage had to be validated – from screening more than 100,000 molecules to confirming safety, efficacy, and visible results*.
2. Multi-dimensional excellence
Skin-brightening science must consider efficacy, safety, diversity, and environmental impact together*. Melasyl™ was selected because it met these standards across research, formulation, and clinical testing.
3. Commitment to inclusivity
The future of cosmetic science must consider every skin tone from the beginning. That means testing across all Fitzpatrick phototypes early in the research process – not after a formula has already been developed.
Your journey starts here
After 18 years of research, more than 100,000 molecules screened, 121 scientific studies, and 23 global patents, Melasyl™ marks a new chapter in dark spot science*. Clinically shown to reduce dark spots by up to 86% in eight weeks, this multi-patented molecule helps intercept melanin precursors before they become visible on the skin*.
Developed with safety, environmental responsibility, and every skin tone in mind, Melasyl™ brings advanced pigmentation research into everyday skincare – and, in the process, translates science and formulas into visible results you can see in the mirror.
This is the next generation of skin-brightening science: Melasyl™.
